acizumab plus FOLFIRI or FOLFOX as third-line or later treatment in patients with metastatic colorectal cancer after failure of 5-fluorouracil, irinotecan, and oxaliplatin a retrospective analysis
本文档由 3371161 分享于2016-01-25 01:16
acizumab plus FOLFIRI or FOLFOX as third-line or later treatment in patients with metastatic colorectal cancer after failure of 5-fluorouracil, irinotecan, and oxaliplatin a retrospective analysis
下载文档
收藏
打印
分享：
君，已阅读到文档的结尾了呢~~